What they were paid
Evommune Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $0 | — | $0 | — | $0 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Evommune, Inc. DEF 14A filed April 21, 2026, accession 0001193125-26-166747, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Evommune, Inc. filed document, accession 0001193125-26-166747. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.
Get the Evommune Board Governance Report
$0 François Beaubien, Ph.D., C.F.A, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Evommune pays directors a $40,000 cash retainer and $220,000 in Options.
The rest of the Evommune board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Arthur Kirsch | Independent Director | $451,244 |
| Benjamin F. McGraw III, Pharm.D | Chair of the Board | $490,827 |
| David E. Cohen, M.D., M.P.H | Independent Director | $484,577 |
| Derek DiRocco, Ph.D | Independent Director | $0 |
| Eugene A. Bauer, M.D | Director | — |
| Felice Verduyn-van Weegen | Independent Director | $0 |
| Luis Peña | Director | — |
| Rob Hopfner, R.Ph., Ph.D | Independent Director | $0 |
The full Evommune compensation record
free company briefThis page is one director within Evommune's record. The company brief lists every named executive and director, each linking to their own page.
Order EVMN
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.